10.1002/adsc.201700975
Advanced Synthesis & Catalysis
Acknowledgements
Benzyl
hydroxy((3aR,5S,9bR)-3-methyl-9b-
(trifluoromethyl)-1,3,3a,4,5,9b-hexahydronaphtho[2,1-
c]isoxazol-5-yl)carbamate (7a): Starting from 3a and N-
methylhydroxylamine hydrochloride and following the
general procedure indicated above, 7a (51% overall yield)
was obtained as a mixture of its diastereoisomers (d.r.=3/1),
which were separated by flash chromatography [n-hexane-
EtOAc (10:1 to 4:1)]. Major diasteroisomer (81 mg,
colorless oil): [α]D = -103.3° (c 1.0; CHCl3). H NMR
(300 MHz, Chloroform-d) δ 9.24 (br s, 1H), 7.60 – 7.24 (m,
9H), 5.65-5.57 (m, 1H), 5.28 (d, J = 12.3 Hz, 1H), 5.22 (d,
We gratefully thank the Spanish Ministerio de Economía y
Competitividad (CTQ-2013-43310-P to S.F. and C.P. and FEDER-
CTQ2016-76155-R to P.M. and T.T.), the Generalitat Valenciana
(GV/PrometeoII/2014/073) and the Gobierno de Aragon
(Grupos Consolidados E-10). F.R.-A. thanks the Spanish
Ministerio de Educación, Cultura y Deporte for a predoctoral
fellowship (FPU14/03520). The authors thankfully acknowledge
the resources from the supercomputers "Memento" and “Cierzo”,
technical expertise and assistance provided by BIFI-ZCAM
(Universidad de Zaragoza, Spain). Technical and human support
25
1
J = 12.3 Hz, 1H), 4.63 (d, J = 9.3 Hz, 1H), 3.92 (dq, J = 9.3, provided by SGIker (UPV/EHU, MINECO, GV/DJ, ERDF, and
ESF) is gratefully acknowledged.
1.6 Hz, 1H), 3.21 (t, J = 3.9 Hz, 1H), 2.72 (s, 3H), 2.37 (dt,
J = 15.6, 4.7 Hz, 1H), 2.27 – 2.17 (m, 1H). 13C NMR (75
MHz, Chloroform-d) δ 156.2 (C=O), 136.4, 132.9, 132.6,
129.8, 129.3, 129.1, 128.7, 128.6, 128.6, 128.4, 127.0 (CF3,
q, J = 282.4 Hz), 74.5, 67.9, 65.6, 57.5 (C-CF3, q, J = 24.5
Hz), 53.6, 42.3, 27.4. 19F NMR (282 MHz, Chloroform-d) δ
-71.41 (s, 3F). HRMS (ESI/Q-TOF) m/z: [M+H]+ Calcd for
C21H22F3N2O4 423.1526; found 423.1534. HPLC (Chiralcel
IC, 85:15 hexane/ iPrOH, 1 mL/min) tR(major) = 8.39 min,
tR(minor) = 16.64 min. Minor diasteroisomer (27 mg,
References
[1] For some representative examples of the preparation of
biologically relevant tetralins, see: a) S. Roesner, J. M.
Casatejada, T. G. Elford, R. P. Sonawane, V. K.
Aggarwal, Org. Lett. 2011, 13, 5740; b) S. M. N.
Efange, A. B. Khare, K. von Hohemberg, R. H. Mach,
S. M. Parsons Z. Tu, J. Med. Chem. 2010, 53, 2825; c)
Z. Tu, S. M. N. Efange, J. Xu, S. Li, L. A. Jones, S. M.
Parsons, R. H. Mach, J. Med. Chem. 2009, 52, 1358; d)
A. Zhang, J. L. Neumeyer, R. J. Baldessarini, Chem.
Rev. 2007, 107, 274; e) G. A. Kraus, I. Geon, Org. Lett.
2006, 8, 5315; f) M. Garrido, J. G. Urones, Tetrahedron
Lett. 2003, 44, 5419; g) V. Nair, R. Rajan, N. P. Rath,
Org. Lett. 2002, 4, 1575; h) M. Lautens, T. Rovis,
Tetrahedron 1999, 55, 8967;(i) E. C. Bucholtz, R. L.
Brown, A. Tropsha, R. G. Booth, S. D. Wyrick, J. Med.
Chem. 1999, 42, 3041; j) R. S. Ward, Nat. Prod. Rep.
1999, 16, 75.
1
colorless oil): H NMR (300 MHz, Chloroform-d) δ 7.52 –
7.25 (m, 9H), 6.19 (br s, 1H), 5.40 (dd, J = 12.2, 5.2 Hz,
1H), 5.34 (d, J = 12.1 Hz, 1H), 5.21 (d, J = 12.1 Hz, 1H),
4.53 (d, J = 8.8 Hz, 1H), 3.80 (dq, J = 8.8, 1.5 Hz, 1H),
3.17 (t, J = 3.2 Hz, 1H), 2.69 (s, 3H), 2.58 (ddd, J = 14.3,
12.2, 3.2 Hz, 1H), 2.00 (ddd, J = 14.3, 5.2, 3.2 Hz, 1H). 13
C
NMR (75 MHz, Chloroform-d) δ 157.8 (C=O), 135.8,
134.5, 133.5, 129.5, 128.8, 128.6, 128.4, 128.4, 128.3,
126.9 (CF3, q, J = 274.4 Hz), 125.9, 74.8, 68.6, 67.3, 57.8
(C-CF3, q, J = 24.1 Hz), 53.9, 42.8, 24.1. 19F NMR (282
MHz, Chloroform-d) δ -69.87 (s, 3F). HPLC (Chiralcel IC,
90:10 hexane/ iPrOH, 1 mL/min) tR(major) = 9.87 min,
tR(minor) = 6.68 min.
[2] a) The term “privileged structure” was introduced in
1988 as a molecular scaffold that is highly represented
in biologically active compounds (capable of binding to
multiple receptors with high affinity). B. E. Evans, K. E.
Rittle, M. G. Bock, R. M. DiPardo, R. M. Freidinger, W.
L. Whitter, G. F. Lundell, D. F. Veber, P. S. Anderson,
R. S. L. Chang, V. J. Lotti, D. J. Cerino, T. B. Chen, P.
J. Kling, K. A. Kunkel, J. P. Springer, J. Hirshfield, J.
Med. Chem. 1988, 31, 2235; b) D. A. Horton, G. T.
Bourne, M. L. Smythe, Chem. Rev. 2003, 103, 893; c)
M. E. Welsch, S. A. Snyder, B. R. Stockwell, Curr.
Opin. Chem. Biol. 2010, 14, 347.
General procedure for the synthesis of fluorinated
diamino alcohols
To a solution of the corresponding isoxazolidine 5 or 7 (0.2
mmol) in dry ethanol (0.05 M), Raney ® Nickel (0.5 mL as
a slurry in water) was added and the resulting mixture was
stirred at room temperature under a hydrogen atmosphere
(balloon) for 16 h. The reaction mixture was then filtered
through Celite, dried over anhydrous Na2SO4 and
concentrated under reduced pressure to afford the
corresponding diaminoalcohol without further purification.
(5S,6S,8S)-8-(aminomethyl)-6-(methylamino)-5-
(trifluoromethyl)-5,6,7,8-tetrahydronaphtho[2,3-
d][1,3]dioxol-5-yl)methanol (8c): Starting from 5c and
following the general procedure indicated above, 8c was
[3] a) E. P. Gillis, K. J. Eastman, M. D. Hill, D. J.
Donnelly, N. A. Meanwell, J. Med. Chem. 2015, 58,
8315; b) S. Purser, P. R. Moore, S. Swallow, V.
Gouverneur, Chem. Soc. Rev. 2008, 37, 320; c) K.
Müller, C. Faeh, F. Diederich, Science 2007, 317, 1881.
1
obtained in quantitative yield (66 mg, pale yellow oil). H
NMR (300 MHz, Chloroform-d) δ 6.92 (s, 1H), 6.74 (s,
1H), 5.92 (s, 2H), 4.19-4.09 (s, 2H), 3.30 (dd, J = 6.2, 3.8
Hz, 1H), 3.10 – 2.92 (m, 2H), 2.88 – 2.73 (m, 1H), 2.50 (s,
3H), 2.17-1.97 (m, 2H). 13C NMR (75 MHz, Chloroform-d)
δ 147.8, 146.8, 133.1, 127.2 (CF3,q, J = 285.5 Hz), 123.5,
109.2, 107.9, 101.4, 65.3, 57.6, 51.1 (C-CF3, q, J = 21.3
Hz), 47.5, 37.7, 34.5, 26.1. 19F NMR (282 MHz,
Chloroform-d) δ -68.65 (s, 3F). HRMS (ESI/Q-TOF) m/z:
[M+H]+ Calcd for C19H20F3N2O4S 333.1421; found
333.1423.
[4] For
recent
reviews
on
fluorine-containing
pharmaceuticals, see: a) Y. Zhou, J. Wang, Z. Gu, S.
Wang, W. Zhu, J. L. Aceña, V. A. Soloshonok, K.
Izawa, H. Liu, Chem. Rev. 2016, 116, 422; b) J. Wang,
M. Sánchez-Roselló, J. L. Aceña, C. del Pozo, A.
Sorochinsky, S. Fustero, V. A. Soloshonok, H. Liu,
Chem. Rev. 2014, 114, 2432.
[5] For reviews on trifluoromethylation of organic
compounds see, for example: a) T. Liang, C. N.
9
This article is protected by copyright. All rights reserved.